Repetitive Sequences in the Murein-Lipoprotein of the Cell Wall of Escherichia Coli (Covalent Lipid/Peptidoglyean/Mucopeptide) V

Total Page:16

File Type:pdf, Size:1020Kb

Repetitive Sequences in the Murein-Lipoprotein of the Cell Wall of Escherichia Coli (Covalent Lipid/Peptidoglyean/Mucopeptide) V 2354 Corrections: Proc. Nat. Acad. Sci. USA 69 (1972) Correction. In the article "A Structure of Pyridine Correction. In the article "Insulin Receptors in Human Nucleotides in Solution," by Oppenheimer, N. J., Arnold, Circulating Cells and Fibroblasts," by Gavin, J. R., III, L. J. & Kaplan, N. O., which appeared in the December Roth, J., Jen, P. & Freychet, P., which appeared in the 1971 issue of Proc. Nat. Acad. Sci. USA 68, 3200-3205, March 1972 issue of Proc. Nat. Acad. Sci. USA 69, 747- the column heads for Table 1, p. 3202, should read: 751, the fifth line from the bottom of the right-hand column on p. 747 should read "Tris buffer [25 mM Tris- PC4HA PC4HB J5-4A J5-4B 10 mM dextrose-1 mM EDTA-1.4 mM sodium acetate- 5.0 mM KCI-120 mM NaCl-2.4 mM MgSO4-1% bovine serum albumin (pH 7.4)]." Correction. In the article "Effect of Dibutyryladenosine 3': 5'-Cyclic Monophosphate on Growth and Differen- Correction. In the article "Repetitive Sequences in the tiation in Caulobacter crescentus," by Shapiro, L., Agabian- Murein-Lipoprotein of the Cell Wall of Escherichia coli," Keshishian, N., Hirsch, A. & Rosen, 0. M., which ap- by Braun, V. & Bosch, V., which appeared in the April peared in the May 1972 issue of Proc. Nat. Acad. Sci. 1972 issue of Proc. Nat. Acad. Sci. USA 69, 970-974, USA 69, 1225-1229, the bacteria-Escherichia coli B- lines 48/49, page 972, should read: ...treated with di- shown in Table 3, p. 1228, should read: Escherichia coli isopropylfluorophosphate, and not (... treated with dini- Crookes. trofluorobenzene). Downloaded by guest on September 28, 2021 Proc. Nat. Acad. Sci. USA Vol. 69, No. 4, pp. 970-974, April 1972 Repetitive Sequences in the Murein-Lipoprotein of the Cell Wall of Escherichia coli (covalent lipid/peptidoglyean/mucopeptide) V. BRAUN* AND V. BOSCH* Max-Planck-Institut fXr Biologie, Tabingen, West Germany Communicated by Eugene P. Kennedy, February 3, 1972 ABSTRACT The amino-acid sequence of the murein- lipoprotein further. Of special interest were the attachment lipoprotein of the Escherichia coli cell wall is presented. sites of the covalently linked lipid and the murein to the This protein is covalently bound to a lipid component as well as to the murein (peptidoglycan, mucopeptide). The polypeptide chain. We report here the complete amino-acid sequence is also highly repetitive. At the N-terminal por- sequence of the protein, the attachment site of the lipid, tion, there are three adjacent almost identical sequences, and the mode of binding of the lipoprotein on the murein. indicating repeated duplication of a gene coding originally Experimental details and the complete list of sequenced for 15 amino acids. The C-terminal part of the poly- peptide chain is more variable but still shows striking peptides will be published elsewhere. homology when certain sequence gaps are introduced. The lipid is bound to the N-terminal serine of the di- METHODS peptide (Ser-Ser) that extends from the repetitive se- Experimental procedure quence. At the C-terminal end where the murein is bound, a tripeptide extends from the repetitive portion. Here there The following preparations and techniques have been de- are several basic amino acids and the only aromatic amino scribed (2-4): isolation of murein-lipoprotein complex from acid in the lipoprotein. The sequence is Lys-Tyr-Arg- E. coli B, grown to 5 X 108 cells/ml in glucose-minimal Lys. The linkage to the murein is formed between the -amino group of the C-terminal lysine and the carboxyl medium (6) or Difco M3; digestion of murein-lipoprotein group of the optical L-center of meso-diaminopimelic with hen egg white lysozyme (EC 3.2.1.17) and isolation acid. The polypeptide chain is composed of 57 amino of lipoprotein either by precipitation at pH 3.7 or chroma- acids and lacks glycine, proline, cysteine, phenylalanine, tography on Sephadex G-75; preparation of murein from a histidine, and tryptophan. 63% of the amino acids are hy- with Pronase drophilic, but because of the covalently linked lipid this digest of murein-lipoprotein complex (EC structural membrane protein has very hydrophobic prop- 3.4.4), preparation of a lipopeptide (7) from such a digest, erties. partial acid hydrolysis of murein, isolation of a murein repeating unit or a portion of the murein peptide side chain The cell wall of Escherichia coli is a favorable system for containing in addition 1 mol of lysine and arginine (3, 4); obtaining insight into the molecular organization of biological amino-acid and amino-sugar analysis on a Unichrom amino- membranes by chemical means. It contains the so-called acid analyzer (Beckman, Munich). rigid layer, which is linked together by covalent bonds. The structure of this layer is therefore preserved even under Preparation of peptides rigorous isolation conditions during which other membranes The peptides used for determination of the amino-acid are dissociated into their individual components with ir- sequence were obtained from digests of the murein-lipo- reversible loss of their in vivo arrangement. protein complex with Pronase, thermolysin, subtilisin The basic structure of the rigid layer is the murein (peptido- (EC 3.4.4.16), or trypsin (EC 3.4.4.4). For example, glycan, mucopeptide), which consists of polysaccharide 3.2 g murein-lipoprotein complex in 300 ml of 0.01 M Tris- chains crosslinked by short peptide bridges (1). It forms a HCl buffer were digested for 2 hr at 60° with Pronase (pH net that encloses the whole cell. From our previous studies 7.5) or thermolysin (pH 8). Insoluble murein was removed (2-5) we concluded that, depending upon the size of the by a 2-hr centrifugation at 37,000 X g, and then lipopeptide cell, about 105 lipoprotein molecules are covalently linked to was precipitated by adjusting the pH oA the clear supernatant the murein of one cell. We further hypothesized that these to 3.2. The soluble peptides were chromatographed. lipoprotein molecules may represent the covalently anchored Special treatments were necessary to cleave the insoluble core of subunits of which the cell wall is built. The other com- lipoprotein with trypsin. Lipoprotein still bound to the ponents of the cell wall could be organized around the lipo- murein, lysozyme-released lipoprotein dispersed by soni- protein so that the pattern of lipoprotein molecules on the fication, lipoprotein treated with maleic anhydride (8), or murein would reflect the overall organization of the cell lipoprotein dispersed in 8 M urea and then diluted to 0.1 M wall. To support this model, we studied the structure of the urea were incubated with trypsin [protein: enzyme ratio 50:1 (w/w) I for 15 hr at 370 at pH 8-9. Hydrolysis with Abbreviations: Dpm, meso-2.6-diaminopimelic acid; MurNAc, trypsin was incomplete but fortunately yielded different N-acetylmuramic acid. peptide spectra. The soluble peptides were separated into * Present address: Max-Planck-Institut ffir Molekulare Genetik, groups by column chromatography on Dowex 50 X 2 with 1000 Berlin 33, Ihnestrasse 63-73, Germany. the following logarithmic gradient: starting with 0.1 M 970 Proc. Nat. Acad. Sci. USA 69 (1972) Structure of Murein-Lipoprotein 971 pyridine adjusted to pH 2 with formic acid, the molarity and as shown in Fig. 1. The sequence is presented to show maximal pH of the pyridine were raised to final values of 2 M and homology between peptides within the polypeptide chain. pH 5.0. The peptides were further purified on phospho- Such a degree of repetition has not previously been ob- cellulose with a gradient as used on Dowex 50 X 2, or on served (see, e.g., discussion in refs. 18 and 19). Starting from Dowex 1 X 2 (9) with an N-ethylmorpholine-pyridine- the third amino acid, a sequence of 14 amino acids is nearly acetate gradient. The purity of the peptides was checked by identically repeated by the next sequence of 15 amino acids paper chromatography with butanol-acetic acid-water followed again by 7 amino acids. The structural gene probably (4:1:5, upper phase), or, for basic peptides, methanol- coded originally for 15 amino acids; it doubled and the water-pyridine-12 N HCl (80:17.5:10:2.5). When only triplet coding for lysine or arginine at the C-terminal end a single spot was observed, the purity was evaluated by was deleted. Then, only half of the original gene was fused determination of the amino-acid composition with the amino- with the doubled gene. Now a more variable part of the acid analyzer. Peptides were usually hydrolyzed in 5.7 N protein starts whose descendence from the original gene is HCl for 20 hr at 1050. However, peptides containing amino obvious when all the following peptides are aligned so that sugars of the murein were hydrolyzed for 15 hr in 4 N HCl they end either with lysine or arginine. The observed ho- at 1050. The amino-acid sequence of peptides was mostly mologies are still striking, but several amino-acid deletions determined by the subtractive Edman procedure (10, 11), (17) have to be introduced. The repetitive N-terminal but the sequences of some were, in addition, directly deter- portion of the polypeptide chain, which has remained essen- mined from the cleaved phenylthiohydantoin derivatives tially constant, may reflect a high selection pressure during of the N-terminal amino acids by chromatography on starch- evolution that allowed only few, and then very conservative, paper (12) or on silica gel thin-layer plates (13). In addition, amino acid replacements (Ile/Val; Gln/Asn/Ser; Ala/Ser; sequential digestions of peptides by carboxypeptidases A and Ala/Thr; Lys/Arg).
Recommended publications
  • THESIS Entitled Studies on Fraction 1 Protein of Beta Vulgaris Submitted for the Degree of DOCTOR of PHILOSOPHY by Kenneth Edwar
    THESIS entitled Studies on Fraction 1 Protein of Beta vulgaris Submitted for the degree of DOCTOR OF PHILOSOPHY by Kenneth Edward Moon 1 970 TABLE OF CONTENTS Acknowledgements i Abbreviations i Summary ii Chapter 1 Introduction 1.1 Carbon Dioxide Fixation in the Calvin • 1 Cycle 1.2 Some Properties of RuDPcase and Similarity 2 to Fraction 1 Protein 1.3 Cellular Location of Fraction 1 Protein 3 1.4 The Mechanism of Action of RuDPcase 4 1.5 Structure of Fraction 1 Protein from 13 Higher Plants 1.6 Relationship of Structure to Enzymic 14 Activity and Role of Sulphydryl Groups 1.7 Studies on RuDPcase from Sources other 17 than the Higher Plants 1.8 Comparison of Some Kinetic and Physical 21 Constants of RuDPcase from Different Sources 1.9 Aim of This Research Project 23 Chapter 2 Methods and Materials 2.1 Plant Material 24 2.2 Preparation of Chloroplasts and Isolation 24 of Fraction 1 Protein 2.3 Concentrating Protein Solutions 26 2.4 Preparation of Reduced and Carboxy- 27 methylated Fraction 1 Protein 2.5 Preparation of Maleyl-carboxymethyl 28 Fraction 1 Protein 2.6 Removal of Maleyl Groups 29 2.7 Gel Electrophoresis 30 2.7 (i) Polyacrylamide Disk Electrophoresis 30 (ii) Polyacrylamide Electrophoresis in 31 the presence of SDS (iii) Slab Acrylamide Gel Electrophoresis 32 (iv) Isoelectric Focusing 33 2.8 Ribulose-1,5-diphosphate Carboxylase 3^ Assay 2.9 Preparation of the S-Sulphenylsulphanate 34 Derivative of Fraction 1 Protein 2.10 Edman Degradations 35 2.11 Hydrazinolysis 35 2.12 Isolation of Blocked N-Terminal Peptides 36 2.13 Tryptic
    [Show full text]
  • Microrna-145 Overexpression Attenuates Apoptosis and Increases Matrix Synthesis in Nucleus Pulposus Cells T
    Life Sciences 221 (2019) 274–283 Contents lists available at ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie MicroRNA-145 overexpression attenuates apoptosis and increases matrix synthesis in nucleus pulposus cells T Jie Zhoua,1, Jianchao Sunb,c,1, Dessislava Z. Markovad, Shuangxing Lib,c, Christopher K. Keplerd, ⁎ ⁎⁎ Junmin Hongb,c, Yingjie Huangb,e, Weijian Chene, Kang Xub,f, Fuxin Weig, , Wei Yeb,c, a Department of Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China b Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China c Department of Spine Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China d Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, USA e Department of Orthopedics, the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China f Experimental Center of Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China g Department of Orthopedics, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China ARTICLE INFO ABSTRACT Keywords: Aims: Lower back pain is often associated with intervertebral disc degeneration (IDD), which results from a Intervertebral disc degeneration decrease in nucleus pulposus (NP) cells and an imbalance between the degradation and synthesis of extracellular Nucleus pulposus matrix (ECM) components. Multiple microRNAs play crucial roles in the modulation of NP cell apoptosis and microRNA-145 matrix degradation. miR-145 is an important microRNA related to degenerative diseases such as osteoarthritis. Apoptosis Here, the effect of miR-145 in IDD was elucidated.
    [Show full text]
  • Repression of Anti-Proliferative Factor Tob1 in Osteoarthritic Cartilage
    Available online http://arthritis-research.com/content/7/2/R274 ResearchVol 7 No 2 article Open Access Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage Mathias Gebauer1*, Joachim Saas2*, Jochen Haag3, Uwe Dietz2, Masaharu Takigawa4, Eckart Bartnik2 and Thomas Aigner3 1Aventis Pharma Deutschland, Functional Genomics, Sanofi-Aventis, Frankfurt, Germany 2Sanofi-Aventis, Disease Group Thrombotic Diseases/Degenerative Joint Diseases, Frankfurt, Germany 3Osteoarticular and Arthritis Research, Department of Pathology, University of Erlangen-Nürnberg, Germany 4Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan * Contributed equally Corresponding author: Thomas Aigner, [email protected] Received: 10 Aug 2004 Revisions requested: 1 Oct 2004 Revisions received: 22 Oct 2004 Accepted: 19 Nov 2004 Published: 11 Jan 2005 Arthritis Res Ther 2005, 7:R274-R284 (DOI 10.1186/ar1479)http://arthritis-research.com/content/7/2/R274 © 2005 Gebauer et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Osteoarthritis is the most common degenerative disorder of the genes were detected between normal and osteoarthritic modern world. However, many basic cellular features and cartilage (P < 0.01). One of the significantly repressed genes, molecular processes of the disease are poorly understood. In Tob1, encodes a protein belonging to a family involved in the present study we used oligonucleotide-based microarray silencing cells in terms of proliferation and functional activity.
    [Show full text]
  • Pronase Kit Pretreatment Reagent 901-PRT957-081017
    Carezyme III: Pronase Kit Pretreatment Reagent 901-PRT957-081017 Catalog Number: PRT957 KH Description: 25 ml, ready-to-use Intended Use: stored under conditions other than those specified in the package For In Vitro Diagnostic Use insert, they must be verified by the user. Diluted reagents should be Carezyme III: Pronase Kit is a concentrated solution of pronase used promptly; any remaining reagent should be stored at 2ºC to 8ºC. enzyme and accompanying buffer intended for use as a pretreatment Troubleshooting: step on formalin-fixed, paraffin-embedded (FFPE) tissues in Follow the antibody specific protocol recommendations according to immunohistochemistry (IHC) and in situ hybridization (ISH) data sheet provided. If atypical results occur, contact Biocare's procedures. The clinical interpretation of any staining or its absence Technical Support at 1-800-542-2002. should be complemented by morphological studies and proper controls Protocol Recommendations: and should be evaluated within the context of the patient's clinical Deparaffinize tissues and hydrate to water. If necessary perform a history and other diagnostic tests by a qualified pathologist. hydrogen peroxide block, wash in water, and rinse in PBS or TBS. The Summary and Explanation: tissue section is ready for protease digestion. Pronase (Streptomyces griseus) is a commonly used digestive enzyme. Manual IHC: In formalinfixed paraffin-embedded tissues, certain antibody or in situ 1. Combine 1 part Pronase concentrate with 4 parts buffer (0.1%). hybridization probes require enzyme pretreatment for proper Incubate for 5-10 minutes at 37ºC. (Strong) immunohistochemical or in situ hybridization staining. CAREZYME III is 2. Combine 1 part Pronase concentrate with 9 parts buffer (0.05%).
    [Show full text]
  • Mediates Neuronal Abeta42 Uptake and Lysosomal Trafficking Rodrigo A
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2010 Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking Rodrigo A. Fuentealba Washington University School of Medicine in St. Louis Qiang Liu Washington University School of Medicine in St. Louis Juan Zhang Washington University School of Medicine in St. Louis Takahisa Kanekiyo Washington University School of Medicine in St. Louis Xiaoyan Hu Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Fuentealba, Rodrigo A.; Liu, Qiang; Zhang, Juan; Kanekiyo, Takahisa; Hu, Xiaoyan; Lee, Jin-Moo; LaDu, Mary Jo; and Bu, Guojun, ,"Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking." PLoS One.,. e11884. (2010). https://digitalcommons.wustl.edu/open_access_pubs/698 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Rodrigo A. Fuentealba, Qiang Liu, Juan Zhang, Takahisa Kanekiyo, Xiaoyan Hu, Jin-Moo Lee, Mary Jo LaDu, and Guojun Bu This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/698 Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Mediates Neuronal Ab42 Uptake and Lysosomal Trafficking Rodrigo A. Fuentealba1,2., Qiang Liu1., Juan Zhang1, Takahisa Kanekiyo1, Xiaoyan Hu2, Jin-Moo Lee2, Mary Jo LaDu3, Guojun Bu1,4* 1 Department of Pediatrics, Washington University School of Medicine, St.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Proteolytic Enzymes
    Proteolytic Enzymes Proteolytic Stock Storage Concentration Reaction Enzyme Solution Temperature in Reaction Buffer Temperature Pretreatment 1 2 Pronase 20mg/mL in H2O –20°C 1mg/mL 0.01M Tris 37°C Self-digestion (pH 7.8) 0.01M EDTA 0.5% SDS 3 Proteinase K 20mg/mL in H2O –20°C 50µg/mL 0.01M Tris 37° to 56°C None required (pH 7.8) 0.005M EDTA 0.5% SDS 1 Pronase is a mixture of serine and acid proteases isolated from Streptomyces griseus. 2 Self-digestion eliminates contamination with DNase and RNase. Self-digested Pronase is prepared by dissolving powdered Pronase in 10mM Tris•Cl (pH 7.5), 10mM NaCl to a final concentration of 20mg/mL and incubating for 1 hour at 37°C. Store the self-digested Pronase in small aliquots at –20°C in tightly capped tubes. 3 Proteinase K is a highly active protease of the subtilisin type that is purified from the mould Tritirachium album Limber. The enzyme has two binding sites for Ca2+, which lie some distance from the active site and are not directly involved in the catalytic mechanism. However, when Ca2+ is removed from the enzyme, approxi- mately 80% of the catalytic activity is lost because of long-range structural changes (Bajorath et al. Nature 1989; 337:481-484). Because the residual activity is usually sufficient to degrade proteins that commonly contaminate preparations of nucleic acids, digestion with Proteinase K is usually carried out in the presence of EDTA (to inhibit the action of Mg2+-dependent nucleases). However, to digest highly resistant proteins such as keratin, it may be necessary to use a buffer con- taining 1mM Ca2+ and no EDTA.
    [Show full text]
  • Protein Digestibility of Cereal Products
    foods Communication Protein Digestibility of Cereal Products Iris Joye Department of Food Science, University of Guelph, Guelph, ON N1G 2W1, Canada; [email protected]; Tel.: +1-519-824-4120 (ext. 52470) Received: 5 May 2019; Accepted: 3 June 2019; Published: 8 June 2019 Abstract: Protein digestibility is currently a hot research topic and is of big interest to the food industry. Different scoring methods have been developed to describe protein quality. Cereal protein scores are typically low due to a suboptimal amino acid profile and low protein digestibility. Protein digestibility is a result of both external and internal factors. Examples of external factors are physical inaccessibility due to entrapment in e.g., intact cell structures and the presence of antinutritional factors. The main internal factors are the amino acid sequence of the proteins and protein folding and crosslinking. Processing of food is generally designed to increase the overall digestibility through affecting these external and internal factors. However, with proteins, processing may eventually also lead to a decrease in digestibility. In this review, protein digestion and digestibility are discussed with emphasis on the proteins of (pseudo)cereals. Keywords: protein digestibility; cereals; pseudocereals; processing; antinutritional factors 1. Introduction Proteins are abundantly present in all living cells, and as such are a vital part of our diet. In order to be usable to the human body after ingestion, dietary proteins have to be hydrolysed into their basic building blocks, i.e., amino acids or small peptides. Hereto, the human gastrointestinal tract possesses an assortment of protein hydrolysing enzymes or peptidases. The physiological roles of proteins are very diverse and range from functioning as pure nitrogen storage molecules over delivering structure building capacity to catalysing a myriad of reactions as metabolically active enzymes or serving as transporter vehicles for poorly soluble or physiologically unstable components [1].
    [Show full text]
  • Partial Characterisation of Dipeptidyl Peptidase 4 (DP 4
    Partial Characterisation of Dipeptidyl Peptidase 4 (DP 4) for the Treatment of Type 2 Diabetes and its Identification as a novel Pharmaceutical Target for Stress-related Indications Beiträge zur Charakterisierung der Dipeptidylpeptidase 4 (DP 4) für die Behandlung von Typ-2-Diabetes und deren Identifizierung als ein neuartiges pharmazeutisches Ziel für stressvermittelte Indikationen Der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg zur Erlangung des Doktorgrades Dr. rer. nat. vorgelegt von M. Sc. (Biochemie) Leona Wagner aus Rheinfelden (Baden) Als Dissertation genehmigt von der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Tag der mündlichen Prüfung: 23.10.2012 Vorsitzender der Promotionskommission: Prof. Dr. Rainer Fink Erstberichterstatter: Prof. Dr. med. Stephan von Hörsten Zweitberichterstatter: Prof. Dr. Johann Helmut Brandstätter Publications, Presentations and Posters Part of the present study have been published or submitted in the following journals or presented on the following conferences: Publications: 1. Hinke, S.A., McIntosh, C.H., Hoffmann, T., Kuhn-Wache, K., Wagner, L., Bar, J., Manhart, S., Wermann, M., Pederson, R.A., and Demuth, H.U. (2002) On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors. Diabetes Care 25, 1490- 1491. 2. Bär, J., Weber, A., Hoffmann, T., Stork, J., Wermann, M., Wagner, L., Aust, S., Gerhartz, B., and Demuth, H.U. (2003) Characterisation of human dipeptidyl peptidase IV expressed in Pichia pastoris. A structural and mechanistic comparison between the recombinant human and the purified porcine enzyme. Biol. Chem. 384, 1553-1563. 3. Engel, M., Hoffmann, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., Huber, R., Bode, W., Demuth, H.U., and Brandstetter, H.
    [Show full text]
  • Enzymes for Cell Dissociation and Lysis
    Issue 2, 2006 FOR LIFE SCIENCE RESEARCH DETACHMENT OF CULTURED CELLS LYSIS AND PROTOPLAST PREPARATION OF: Yeast Bacteria Plant Cells PERMEABILIZATION OF MAMMALIAN CELLS MITOCHONDRIA ISOLATION Schematic representation of plant and bacterial cell wall structure. Foreground: Plant cell wall structure Background: Bacterial cell wall structure Enzymes for Cell Dissociation and Lysis sigma-aldrich.com The Sigma Aldrich Web site offers several new tools to help fuel your metabolomics and nutrition research FOR LIFE SCIENCE RESEARCH Issue 2, 2006 Sigma-Aldrich Corporation 3050 Spruce Avenue St. Louis, MO 63103 Table of Contents The new Metabolomics Resource Center at: Enzymes for Cell Dissociation and Lysis sigma-aldrich.com/metpath Sigma-Aldrich is proud of our continuing alliance with the Enzymes for Cell Detachment International Union of Biochemistry and Molecular Biology. Together and Tissue Dissociation Collagenase ..........................................................1 we produce, animate and publish the Nicholson Metabolic Pathway Hyaluronidase ...................................................... 7 Charts, created and continually updated by Dr. Donald Nicholson. DNase ................................................................. 8 These classic resources can be downloaded from the Sigma-Aldrich Elastase ............................................................... 9 Web site as PDF or GIF files at no charge. This site also features our Papain ................................................................10 Protease Type XIV
    [Show full text]
  • 12225.Full.Pdf
    2626 Corrections Proc. Natl. Acad. Sci. USA 93 (1996) Developmental Biology. In the article ‘‘In vitro generation of Cell Biology. In the article ‘‘Purification, cDNA cloning, hematopoietic stem cells from an embryonic stem cell line’’ by functional expression, and characterization of a 26-kDa en- Ronald Palacios, Eva Golunski, and Jacqueline Samaridis, dogenous mammalian carboxypeptidase inhibitor’’ by Emman- which appeared in no. 16, August 1, 1995, of Proc. Natl. Acad. uel Normant, Marie-Pascale Martres, Jean-Charles Schwartz, Sci. USA (92, 7530–7534), the histograms in Fig. 2 B and C (on and Claude Gros, which appeared in number 26, December 19, p. 7532) were incorrect. The corrected Fig. 2 is illustrated 1995, of Proc. Natl. Acad. Sci. USA (92, 12225–12229), the below. The authors apologize for any inconvenience this may authors request the following correction be noted. The Gen- have caused readers. Bank Accession No. on p. 12225 should read U40260. FIG. 2. Specificity of the 28-8-6 antibody for MHC class I H-2b haplotype. The MHC class I H-2b-specific antibody 28-8-6 stains mononuclear marrow cells from C57BLy6 (H-2b) (A) but not from CB17 SCID (H-2D) (B) or C3H SCID (H-2K) (C) mice. Downloaded by guest on September 23, 2021 Proc. Natl. Acad. Sci. USA Vol. 92, pp. 12225-12229, December 1995 Cell Biology Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor EMMANUEL NORMANT, MARIE-PASCALE MARTRES, JEAN-CHARLES SCHWARTZ, AND CLAUDE GROS* Unite de Neurobiologie et Pharmacologie (U. 109) de l'Institut National de la Sante et de la Recherche Medicale, Centre Paul Broca, 2ter rue d'Alesia, 75014 Paris, France Communicated by William N.
    [Show full text]
  • Identification of the Membrane-Type Matrix Metalloproteinase MT1-MMP
    Journal of Cell Science 110, 589-596 (1997) 589 Printed in Great Britain © The Company of Biologists Limited 1997 JCS9564 Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts Takuya Sato1, Maria del Carmen Ovejero1, Peng Hou1, Anne-Marie Heegaard1, Masayoshi Kumegawa2, Niels Tækker Foged1 and Jean-Marie Delaissé1,* 1Department of Basic Research, Center for Clinical & Basic Research, Ballerup Byvej 222, DK-2750 Ballerup, Denmark 2The First Department of Oral Anatomy, Meikai University School of Dentistry, Keyakidai 1-1, Sakado, Saitama 350-02, Japan *Author for correspondence SUMMARY The osteoclasts are the cells responsible for bone resorp- on bone sections showed that MT1-MMP is expressed also tion. Matrix metalloproteinases (MMPs) appear crucial in osteoclasts in vivo. Antibodies recognizing MT1-MMP for this process. To identify possible MMP expression in reacted with specific plasma membrane areas corre- osteoclasts, we amplified osteoclast cDNA fragments sponding to lamellipodia and podosomes involved, respec- having homology with MMP genes, and used them as a tively, in migratory and attachment activities of the osteo- probe to screen a rabbit osteoclast cDNA library. We clasts. These observations highlight how cells might bring obtained a cDNA of 1,972 bp encoding a polypeptide of MT1-MMP into contact with focal points of the extracel- 582 amino acids that showed more than 92% identity to lular matrix, and are compatible with a role of MT1- human, mouse, and rat membrane-type 1 MMP (MT1- MMP in migratory and attachment activities of the osteo- MMP), a cell surface proteinase believed to trigger cancer clast. cell invasion. By northern blotting, MT1-MMP was found to be highly expressed in purified osteoclasts when compared with alveolar macrophages and bone stromal Key words: Osteoclast, MMP-14, MT1-MMP, Membrane proteinase, cells, as well as with various tissues.
    [Show full text]